| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 11/14/2013 | WO2013167403A1 Substituted 6-(4-hydroxy-phenyl)-1h-pyrazolo[3,4-b]pyridine derivatives as kinase inhibitors |
| 11/14/2013 | WO2013167177A1 Gpr17 receptor modulators. |
| 11/14/2013 | WO2013167112A1 Composition for nasal application |
| 11/14/2013 | WO2013166862A1 Diaryl[a, g]quinolizidine compound, preparation method therefor, pharmaceutical composition, and uses thereof |
| 11/14/2013 | WO2013166654A1 Permeable glycosidase inhibitors and uses thereof |
| 11/14/2013 | WO2013129977A3 Pharmaceutical composition for injections having neuroprotector, antiamnaesic, antioxidant, antihypoxic and antiischaemic activity (embodiments) |
| 11/14/2013 | US20130304167 Heat Patch for Pain |
| 11/14/2013 | US20130303568 Substituted 2-Aminoacetamides and the Use Thereof |
| 11/14/2013 | US20130303506 Amino-derivatives as novel inhibitors of histone deacetylase |
| 11/14/2013 | US20130303435 Smart Pro-Drugs of Serine Protease Inhibitors |
| 11/14/2013 | US20130302889 Differentiation of Bone Marrow Cells into Neuronal Cells and Uses Therefor |
| 11/14/2013 | US20130302418 Controlled release hydrocodone formulations |
| 11/14/2013 | CA2873016A1 Compositions and methods for the treatment of epilepsy |
| 11/14/2013 | CA2872976A1 Compositions and methods for the treatment of neurological disorders |
| 11/13/2013 | EP2662453A2 Detection and treatment of schizophrenia |
| 11/13/2013 | EP2662366A1 Novel triazinedione derivatives as GABA-B receptor modulators |
| 11/13/2013 | EP2662358A1 Catecholamine derivatives and prodrugs thereof |
| 11/13/2013 | EP2662081A1 Therapeutic use of indole-dihydro-imidazole derivatives |
| 11/13/2013 | EP2661445A2 Modulators of il-12 and/or il-23 for the prevention or treatment of alzheimer's disease |
| 11/13/2013 | EP2661436A1 Novel sulfamide piperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof |
| 11/13/2013 | EP2661435A1 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
| 11/13/2013 | EP2661432A1 Pyrrolidine derivatives as nk3 antagonists |
| 11/13/2013 | EP2661268A2 Inhibitors of polo-like kinase |
| 11/13/2013 | EP2661267A1 Fused aminodihydrothiazine derivatives |
| 11/13/2013 | EP2661266A2 Chemosensory receptor ligand-based therapies |
| 11/13/2013 | EP2661263A1 Use of the phytocannabinoid cannabidiol (cbd) in combination with a standard anti-epileptic drug (saed) in the treatment of epilepsy |
| 11/13/2013 | CN1750839B Administration of capsaicinoids |
| 11/13/2013 | CN103391941A Imidazo[5,1-f][1,2,4]triazines for the treatment of neurological disorders |
| 11/13/2013 | CN103391940A Substituted [(5h-pyrrolo[2,1-c] [1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoic acid compounds as dual activity h1 inverse agonists/5-ht2a antagonists |
| 11/13/2013 | CN103391939A Substituted purine and 7 - deazapurine compounds as modulators of epigenetic enzymes |
| 11/13/2013 | CN103391934A Dipyridylamine derivative |
| 11/13/2013 | CN103391928A 1,4-oxazepines as bace1 and/or bace2 inhibitors |
| 11/13/2013 | CN103391923A Benzamide derivatives as p2x7 receptor antagonists |
| 11/13/2013 | CN103391780A Combinations of therapeutic agents for use in the treatment of neurodegenerative diseases |
| 11/13/2013 | CN103391775A Use of the phytocannabinoid cannabidiol (cbd) in combination with a standard anti-epileptic drug (saed) in the treatment of epilepsy |
| 11/13/2013 | CN103387616A Erythropoietin (EPO) variant-Fc fusion protein |
| 11/13/2013 | CN103387583A Diaryl [a, g] quinolizidine compound, preparation method thereof, pharmaceutical composition, and uses thereof |
| 11/13/2013 | CN103387580A Stemona root alkaloid monomer components and applications thereof |
| 11/13/2013 | CN103386131A Pharmaceutical composition containing adenosine or derivative of adenosine |
| 11/13/2013 | CN103386122A Lumbrokinase enteric-coated tablet and preparation method thereof |
| 11/13/2013 | CN103386119A Application of SIRT1 in adjusting rhythm and improving rhythm disorder |
| 11/13/2013 | CN103386112A Application of traditional Chinese medicinal composition in treating mild cold |
| 11/13/2013 | CN103386099A Multifunctional medicinal liquor formula and preparation method |
| 11/13/2013 | CN103386090A Miao medicine for treating neurasthenia, and preparation method thereof |
| 11/13/2013 | CN103386088A Chinese medicine composition for treating insomnia |
| 11/13/2013 | CN103386080A Medicine composite for curing combined external head injuries in clinical nursing |
| 11/13/2013 | CN103386057A Preparation method and application of stemona effective part extract |
| 11/13/2013 | CN103386053A Externally applied medicinal liquor for curing pain |
| 11/13/2013 | CN103386038A Mind tranquilizing and refreshing traditional Chinese medicine bag |
| 11/13/2013 | CN103386031A Drug for treating vascular dementia |
| 11/13/2013 | CN103386030A Drug for treating pediatric epilepsy |
| 11/13/2013 | CN103386021A Brain boosting and intelligence improving zinc rhizoma polygonati oral liquid and preparation technology |
| 11/13/2013 | CN103386018A Drug for treating febrile convulsion in children |
| 11/13/2013 | CN103386013A Medicament for treating insomnia and dreamful sleep |
| 11/13/2013 | CN103386006A Application of traditional Chinese medicinal composition in preparation of medicines for treating dementia |
| 11/13/2013 | CN103386005A Application of traditional Chinese medicinal composition in preparation of medicines for treating study and memory disorders |
| 11/13/2013 | CN103386004A Application of traditional Chinese medicinal composition in preparation of anti-ageing medicines |
| 11/13/2013 | CN103385967A Fleece-flower root-containing traditional Chinese medicine preparation and preparation method thereof |
| 11/13/2013 | CN103385966A Traditional Chinese medicine containing red ginseng and preparation method thereof |
| 11/13/2013 | CN103385965A Tranquilizing and sedative medicine liquid |
| 11/13/2013 | CN103385956A Application of traditional Chinese medicine in preparation of drug used for treating simple schizophrenia |
| 11/13/2013 | CN103385949A Drug for treating headaches due to pathogenic wind-heat |
| 11/13/2013 | CN103385944A Formula for osteoproliferation and application method thereof |
| 11/13/2013 | CN103385941A Chinese herbal medicine pain-relieving medicinal moxibustion |
| 11/13/2013 | CN103385940A Traditional Chinese medicine percolate for reducing lower limb muscle tension of spastic cerebral palsy |
| 11/13/2013 | CN103385937A Traditional Chinese medicine preparation for preventing and treating herpes zoster and postherpetic neuralgia and preparation method thereof |
| 11/13/2013 | CN103385929A A traditional Chinese medicine composition used for treating Alzheimer's dementia, preparation thereof and an application thereof |
| 11/13/2013 | CN103385924A Traditional Chinese medicine sustained-release tablet with pain relieving effect, and preparation method thereof |
| 11/13/2013 | CN103385897A Chinese medicine for treating palpitation, neurasthenia and stomach diseases and preparation method and applications thereof |
| 11/13/2013 | CN103385884A Application of gastrodin to preparing medicaments for preventing and treating Alzheimer's disease |
| 11/13/2013 | CN103385876A Frovatriptan medicine composition and preparation method thereof |
| 11/13/2013 | CN103385871A Compound levodopa microcapsule floating tablet |
| 11/13/2013 | CN103385866A Application of (E)-2-(3,5-dimethoxybenzylidene)-cyclopentanone in preparing medicines used for treating pain diseases |
| 11/13/2013 | CN103385859A Propranolol hydrochloride oral disintegrating tablet used for treating post-traumatic stress disorder, and preparation method thereof |
| 11/13/2013 | CN103385857A Pharmaceutical composition of palipeddone |
| 11/13/2013 | CN103385852A Hydroxyfasudil injection and preparation method thereof |
| 11/13/2013 | CN103385627A Millet-lily pillow flesh |
| 11/13/2013 | CN103385337A Preparation method of herbal tea with function of relieving depression |
| 11/13/2013 | CN103141729B Fruit jelly for giving up drinking |
| 11/13/2013 | CN102886022B Chinese medicinal preparation for treating insomnia and dreaminess |
| 11/13/2013 | CN102885977B Composition with memory improving function |
| 11/13/2013 | CN102871997B Controlled-release medicinal composition containing demethyl venlafaxine benzoate compounds |
| 11/13/2013 | CN102871981B Tablet medicine compound containing levetiracetam |
| 11/13/2013 | CN102836324B Decoction for treating schizophrenia |
| 11/13/2013 | CN102784302B Method for preparing traditional Chinese medicine for treating insomnia caused by deficiency of kidney yin |
| 11/13/2013 | CN102784298B Preparation method of traditional Chinese medicine for treating mustard gourmand type insomnia |
| 11/13/2013 | CN102698205B Semen boitae traditional Chinese medicine preparation for relieving depression and preparation method for preparation |
| 11/13/2013 | CN102698109B Arisaema cum bile Chinese herbal preparation for relieving depression and preparation method of same |
| 11/13/2013 | CN102698053B Nacre Chinese herbal preparation for relieving depression and preparation method of same |
| 11/13/2013 | CN102614147B Slow release tablet containing quetiapine fumarate |
| 11/13/2013 | CN102614109B Active substance-contained gel composite based on multilayer liquid crystal framework and method for producing same |
| 11/13/2013 | CN102526686B Multifunctional health-care smelling medicament |
| 11/13/2013 | CN102406784B Traditional Chinese medicine composition for treating insomnia |
| 11/13/2013 | CN102396950B Health-care and health-promotion pillow |
| 11/13/2013 | CN102267990B 2,3-dihydrobenzofuran derivatives as well as preparation method and application thereof |
| 11/13/2013 | CN102260617B Royal jelly specially-produced wine and preparation technology thereof |
| 11/13/2013 | CN102229562B Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 11/13/2013 | CN102105448B Phenoxypyridinylamide derivatives and use thereof in the treatment of PDE4 mediated disease states |
| 11/13/2013 | CN102083828B Heterocyclic compounds and compositions as C-KIT and PDGFR kinase inhibitors |
| 11/13/2013 | CN102065897B New therapeutic approaches for treating alzheimer disease and related disorders through a modulation of cell stress response |